| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87632 |
|
5,071 |
4,731 |
$903K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,662 |
2,393 |
$802K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,202 |
11,063 |
$555K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,584 |
13,254 |
$499K |
| 87631 |
|
5,224 |
3,822 |
$444K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,055 |
6,385 |
$360K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,441 |
2,394 |
$308K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17,777 |
15,439 |
$210K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,671 |
3,278 |
$135K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,228 |
4,616 |
$99K |
| 99000 |
|
11,455 |
10,483 |
$99K |
| S8301 |
Infection control supplies, not otherwise specified |
5,401 |
4,809 |
$91K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,604 |
2,040 |
$91K |
| 87486 |
|
2,644 |
2,360 |
$62K |
| 87581 |
|
2,642 |
2,357 |
$62K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,285 |
1,523 |
$39K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
378 |
330 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
101 |
101 |
$8K |
| 86328 |
|
238 |
197 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
95 |
90 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
442 |
410 |
$5K |
| 87807 |
|
431 |
402 |
$4K |
| 94760 |
|
1,900 |
1,635 |
$2K |
| 81002 |
|
423 |
402 |
$1K |
| 99051 |
|
3,631 |
3,422 |
$463.14 |
| 81025 |
|
55 |
54 |
$368.73 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
39 |
35 |
$264.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
12 |
12 |
$168.32 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
49 |
41 |
$44.25 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
12 |
12 |
$19.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
39 |
39 |
$9.43 |
| A9150 |
Non-prescription drugs |
333 |
237 |
$2.98 |
| 99072 |
|
19 |
18 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
48 |
42 |
$0.00 |
| 94664 |
|
12 |
12 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
678 |
601 |
$0.00 |
| 36416 |
|
614 |
527 |
$0.00 |